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Running title: PDMS Wells Method for Large Tumor Spheroids
 Abstract 
Multicellular tumor spheroids are widely used as in vitro models for testing of anticancer drugs. 
The advantage of this approach is that it can predict the outcome of a drug treatment on human 
cancer cells in their natural three-dimensional environment without putting actual patients at risk. 
Several methods were utilized in the past to grow submillimeter-size tumor spheroids. However, 
these small models are not very useful for preclinical studies of tumor ablation where the goal is 
the complete destruction of tumors that can reach several centimeters in diameter in the human 
body. Here, we propose a PDMS well method for large tumor spheroid culture. Our experiments 
with HepG2 hepatic cancer cells show that three-dimensional aggregates of tumor cells with a 
volume as large as 44 mm3 can be grown in cylindrical PDMS wells after the initial culture of 
tumor cells by the hanging drop method. This is a 350 times more than the maximum volume of 
tumor spheroids formed inside hanging drops (0.125 mm3).  
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Many types of tumor cells have a tendency to form multicellular aggregates of spheroidal 
shape when they grow under the conditions preventing significant adhesion of the cells to the 
walls of the culture vessel 1. These aggregates, known as multicellular tumor spheroids 
(MCTSs), are a popular in vitro model for preclinical testing of anticancer therapy 2. One of the 
standard techniques for MCTS culture is the hanging drop method in which tumor spheroids 
form at the bottom of up-ending droplets of cell growth medium 3. This method produces 
MCTSs with the effective diameter of ~300 µm 4, two orders of magnitude less than the size of 
advanced tumors in vivo (> 3 cm) 5. Small tumor spheroids are a useful model to study cellular 
response to chemotherapeutic drugs, but they cannot fully predict whether a specific cancer 
treatment is able to eradicate the tumor mass. Knowledge of this information is especially 
important for the development of optimized tumor ablation modalities 6. While the preparation of 
tumor spheroids with the size of advanced tumors is out of reach because of the absence of 
vasculature in the spheroids, the limit in the spheroid size has not yet been reached.  
The nature of tumor cells causes them to spread out and cover as much surface as 
possible, which is detrimental to spheroid formation. Several methods were suggested to prevent 
this spreading and thus force the cells to form three-dimensional aggregates. The growth of the 
tumor cell aggregates has been shown to correlate directly to the seeding density and initial size 
of tumor cells 7. In some of the approaches, cell surface receptors were altered to allow less 
binding with surfaces and more binding between cells 8. Others utilize non-adhesive surfaces 9 or 
porous scaffolds 10 to grow tumor cells into a desired three-dimensional shape. In the liquid 
overlay technique, tumor cells are placed in a gel composed of agarose or another biopolymer. 
The gel is fully submerged in a growth medium with nutrients that reach tumor cells through 
diffusion in the gel 11. Cell spinning methods can result in larger spheroids (< 2 mm) than other 
existing techniques can produce, but they require expensive equipment to prevent excessive 
shear to the cells 12.  
Soft lithographic procedures have been utilized to create synthetic scaffolds for spheroid 
production 13, 14 or hemi-spherical “rifts” on microchannel walls 15. The latter approach, referred 
to as a microbubble array, has been recently used to culture spheroids of colon cancer cells under 
physiological flow conditions 16. The size of MCTSs produced by this method cannot exceed the 
rift diameter, which is 500 µm or less. In addition, the requirement for the cells to flow in the 
channels is detrimental to tumor generation. Other groups used polydimethylsiloxane (PDMS) to 
make micro wells, but due to the well size, it only allowed for small spheroid sizes 17. One way 
to generate large tumor spheroids is to perfuse free floating cells together with rigid 
microspheres coated with cell adhesion molecules through a microchannel. Tumor cells attach to 
these particles and eventually form large spheroids 18. The problem with this approach is that the 
core of such MCTSs is a synthetic structure but not a necrotic core as in natural tumors. This 
creates significantly different conditions for cell growth than the conditions existing in tumors in 
vivo. 
In this paper, we used specially fabricated wells in which the substrate was divided into 
two parts: an adhesive center that served as an anchor for a spheroid and a non-adhesive 
periphery made of untreated PDMS that prevented cell spreading. We hypothesize that the initial 
clusters of tumor cells (prepared, for instance, by the hanging drop method) must be anchored to 
a surface to properly grow into a large-volume three-dimensional aggregate. It should be noted 
that the majority of tumor cells in the body are of epithelial origin (carcinoma). These cells grow 
in an anchorage-dependent manner, as shown previously 19-21. Here, we report about the design 
of the PDMS wells with different diameters using soft lithography and the growth of large tumor 
aggregates in the wells. 
 
Human hepatocellular carcinoma cell line HepG2 was purchased from ATCC. They were 
grown under the 37°C 5% CO2 conditions in T-75 culture flasks in Dulbecco's Modified Eagle's 
Medium supplemented with 10% fetal bovine serum and antibiotics/antimycotics (Invitrogen). 
When reaching more than 80% confluence, the cells were detached by using 0.05% trypsin 
(Invitrogen) and then re-suspended in a new flask. These procedures were repeated until the cells 
reached passage 4 or 5. 
The hanging drop method 3, 4 was utilized to grow initial clusters of tumor cells. In this 
method, 35 µl drops of suspension culture with ~106 cells/ml were placed on the lid of a 
BD Falcon™ 24-well multiwell plate. The lid was then inverted and the drops were allowed to 
hang for several days. According to our measurements, the cluster size reached a saturated value 
of about 310 µm in three days (Fig. 1a). Figure 1(b) shows the top view of this cluster.  
The clusters prepared by the hanging drop method were transferred to micro-centrifuge 
tubes via gentle suction by a pipette and centrifuged at 125×g for 5 minutes to ensure the strong 
attachment between cells. The pellets were then transferred to the PDMS wells (one hanging 
drop culture per one PDMS well) to further grow into larger aggregates. The centrifugation to 
pellet tumor cells has previously been used to generate initial tumor spheroids11. 
To prepare PDMS wells, 36 g of liquid PDMS (Skylgard 184 Silicone Elastomer Base) 
was mixed with 3.6 g (10% weight/weight) of Skylgard 184 Silicone Elastomer Curing Agent 
(Ellsworth Adhesives, Germantown, WI).  The resulting solution was poured equally into each 
well of a 24 well plate with the insertion of metal rods of diameters 3, 5, and 8 mm as molds and 
allowed to solidify in a Fisher Scientific Isotemp 500 series oven at 80°C for 3 hrs (Fig. 2). The 
final height of the wells was 9 mm. Cell pellets were placed into the PDMS wells (Fig. 2) and 
grew at 37°C in 5% CO2 a New Brunswick Galaxy 48 R incubator for 14 days.  
The growth medium was changed in the wells every day from day 1 to 10 and then every 
12 hours after day 10. During this procedure, only the top layer (~80%) of the medium was 
removed to ensure tumor cells are submerged at all times. SYTOX green and C12 Resazurin red 
staining of cells was done afterwards to show both live (red) and dead cells (green) in the same 
sample.  
The aggregate growth was measured by using a Nikon Eclipse TiS microscope equipped 
with a high-speed camera (QImaging Retiga EXi). Notches in the fine adjustment knob of the 
microscope were used as a ruler to measure the height of the aggregates, with each notch equal to 
0.1 mm in height according to the manufacturer information. This method was verified by the 
height measurements from Z-stack images of tumor spheroids obtained using Olympus IX70 
microscope (Olympus America, Inc., Melville, NY) coupled with a Photometrics CoolSNAP EZ 
camera (less than 10% difference between results gained between the z-stack and knob turning 
methods). The aggregate volume V was estimated from its height h and diameter d (measured 
from the bottom-view image of the spheroid) under the assumption the aggregate shape is a 
cylinder with a circular cross section: V = πhd2/4. The true volume of the aggregate may be 
slightly less than the cylinder volume due to curvature of its top surface. However, this deviation 
is expected to be less than 33%, where the aggregate shape approaches a semi-ellipsoidal cap: V 
= πhd2/6. At least four independent experiments per each diameter of the PDMS well were 
conducted. The data were plotted and statistically analyzed by using Prism 5.0.2 (GraphPad 
Software). Statistical significance was determined by Student’s t-test or one-way ANOVA with 
Bonferroni’s multiple comparison test.  
 
Figure 3(a, b) shows fluorescent images of HepG2 cell aggregate grown in 5 mm 
diameter PDMS wells for 5 days, with live/dead cell staining applied one hour before imaging. 
Additional images of HepG2 spheroids, cultured in PDMS wells for 7 days, are displayed in 
Figure 4. As seen in these images, HepG2 cells grow in PDMS wells as a single tightly-packed 
three-dimensional aggregate that has an outer layer of proliferating cells and an inner necrotic 
core, which is the structure typical for early-stage, avascular tumors in vivo. It is important to 
mention that the cells that put into PDMS wells without prior hanging drop culture form loose 
clusters without a three-dimensional structure (Fig. 3c). Similarly, HepG2 cell clusters do not 
grow into larger aggregates when they are not permitted to attach to the bottom of PDMS wells.     
Figure 5 shows the effect of the PDMS well diameter on the volume of tumor cell 
aggregates. The maximum volume increased from 0.125 mm3 at day 0 to the value between 10 
mm3 (in ≤3 mm wells) and 44 mm3 (in ≥5 mm wells) at day 10. ANOVA shows statistically 
significant difference (p < 0.0001) in the aggregate volume between ≥5 mm wells and ≤3 mm 
wells. The effective diameter of the aggregates in 5 mm PDMS wells, calculated using the 
spherical volume formula, is around 2.19 mm. This is seven times more than the mean size of 
initial clusters prepared using the hanging drop method (0.31 mm).   
In summary, we presented a simple method to culture millimeter-size three-dimensional 
aggregates of tumor cells using a PDMS scaffold. By using this PDMS well method, tumor 
aggregates grew to the maximum volume of 44 mm3 in about 13 days (including 3 days of 
hanging drop culture), which was much higher than the volume of the spheroids obtained using 
the handing drop method (~0.125 mm3). The proposed technique can be further modified to grow 
bigger tumor cell aggregates by fabricating multi-level microchannels in PDMS to provide 
nutrients to tumor cells. These embedded microchannels can also be utilized to fine tune the 
aggregate shape. The design of such bioreactors for MCTS culture will be the focus of our future 
investigations and will eventually provide a three-dimensional in vitro tumor model for testing 
tumor ablation modalities and other methods for destruction of advanced and metastatic tumors.  
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Figure legends 
Figure 1: (a) Growth rate of HepG2 cell clusters during culture by the hanging drop method. 
Mean ± SD of six independent tests. Measurements were taken using Nikon Eclipse TiS 
microscope. (b) Top view of a HepG2 cell cluster (dark region) at the bottom of a hanging drop 
after three days in culture. Solid white lines are micrometer ticks that show that the effective 
diameter of this cluster is ~310 µm. 100X magnification. The image was taken using Nikon 
Coolpix 12 MP camera. 
 
Figure 2: Three-dimensional culture of tumor aggregates in PDMS wells: the image of a PDMS 
well with a HepG2 aggregate (red) formed after five days in culture (top left), schematic of a 
PDMS well (middle and bottom left), and the image showing the aggregates growing in the wells 
of different diameter (right).   
 
Figure 3: Tumor aggregate grown in 5 mm diameter PDMS wells for 5 days. (a) Image of an 
aggregate taken using a green filter. Bright green fluorescence indicates dead cells. (b) Overlay 
of aggregate images taken using green and red filters (green on top of red). Red fluorescence 
indicates live cells. (c) Without prior culture by the handing drop method, tumor cells do not 
form a three-dimensional compact aggregate in PDMS wells.  Bar: 100 µm.  
 
Figure 4: Gallery of HepG2 spheroids cultured in 5 mm diameter PDMS wells for 7 days. 
Shown are the overlays of spheroid images taken using red and green filters (red on top of 
green). The background of the images was darkened.  Bar: 100 µm.  
 
Figure 5: (a) Growth rate of HepG2 aggregates during culture in PDMS wells of different 
diameter. Mean of four independent tests. (b) Volume of HepG2 aggregates cultured in PDMS 
wells of different diameter for 10 days. The aggregate volume was calculated using the 
cylindrical model. Mean ± SD of four independent tests. * p < 0.0001.  
